BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20374275)

  • 1. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial.
    Hummel M; Spiess B; Cornely OA; Dittmer M; Mörz H; Buchheidt D
    Eur J Haematol; 2010 Aug; 85(2):164-9. PubMed ID: 20374275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients.
    Lass-Flörl C; Gunsilius E; Gastl G; Freund M; Dierich MP; Petzer A
    Mycoses; 2005; 48 Suppl 1():12-7. PubMed ID: 15826281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
    Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
    Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
    Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S
    Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.
    Buchheidt D; Baust C; Skladny H; Ritter J; Suedhoff T; Baldus M; Seifarth W; Leib-Moesch C; Hehlmann R
    Clin Infect Dis; 2001 Aug; 33(4):428-35. PubMed ID: 11462176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay.
    Hummel M; Spiess B; Kentouche K; Niggemann S; Böhm C; Reuter S; Kiehl M; Mörz H; Hehlmann R; Buchheidt D
    J Clin Microbiol; 2006 Nov; 44(11):3989-93. PubMed ID: 16943359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance.
    Suarez F; Lortholary O; Buland S; Rubio MT; Ghez D; Mahé V; Quesne G; Poirée S; Buzyn A; Varet B; Berche P; Bougnoux ME
    J Clin Microbiol; 2008 Nov; 46(11):3772-7. PubMed ID: 18845828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.
    Botterel F; Farrugia C; Ichai P; Costa JM; Saliba F; Bretagne S
    Transpl Infect Dis; 2008 Oct; 10(5):333-8. PubMed ID: 18627580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
    Lass-Flörl C; Gunsilius E; Gastl G; Bonatti H; Freund MC; Gschwendtner A; Kropshofer G; Dierich MP; Petzer A
    J Clin Microbiol; 2004 Sep; 42(9):4154-7. PubMed ID: 15365004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients.
    Raad I; Hanna H; Sumoza D; Albitar M
    Cancer; 2002 Feb; 94(4):1032-6. PubMed ID: 11920473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
    Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
    J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients.
    Buchheidt D; Hummel M; Schleiermacher D; Spiess B; Schwerdtfeger R; Cornely OA; Wilhelm S; Reuter S; Kern W; Südhoff T; Mörz H; Hehlmann R
    Br J Haematol; 2004 Apr; 125(2):196-202. PubMed ID: 15059142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Florent M; Katsahian S; Vekhoff A; Levy V; Rio B; Marie JP; Bouvet A; Cornet M
    J Infect Dis; 2006 Mar; 193(5):741-7. PubMed ID: 16453271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.
    Millon L; Piarroux R; Deconinck E; Bulabois CE; Grenouillet F; Rohrlich P; Costa JM; Bretagne S
    J Clin Microbiol; 2005 Oct; 43(10):5097-101. PubMed ID: 16207969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.
    Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Dellow E; Herbrecht R; Donnelly JP
    Mycoses; 2011 Sep; 54(5):e449-55. PubMed ID: 21039936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
    El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
    Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspergillus antigen and PCR assays in bone marrow transplanted children.
    Bialek R; Moshous D; Casanova JL; Blanche S; Hennequin C
    Eur J Med Res; 2002 Apr; 7(4):177-80. PubMed ID: 12010653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
    Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R;
    Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.
    White PL; Linton CJ; Perry MD; Johnson EM; Barnes RA
    Clin Infect Dis; 2006 Feb; 42(4):479-86. PubMed ID: 16421791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY; Boktour MR; Hanna HA; Husni RN; Torres HA; Afif C; Kontoyiannis DP; Raad II
    Cancer; 2008 Mar; 112(6):1282-7. PubMed ID: 18224662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.